Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idraparinux vs biotinylated idraparinux in acute lower-limb deep vein thrombosis
2005-005326-30Phase 3Completed
- Sponsor
- Sanofi
- Start
- Feb 2006
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of SSR-126517E, idraparinux and avidin in deep vein thrombosis (DVT) (2 arms), sponsored by Sanofi. Primary endpoints: Time course to steady state achievement and Bioequipotency at steady state. Started Feb 2006; status: completed.
02
Drugs
SSR-126517Eidraparinuxavidin
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on 2005-005326-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005326-30.